Department of Internal Medicine

Medicine & Life Sciences

1. Bacteremia 22%
2. Helicobacter pylori 20%
3. Therapeutics 17%
4. Infections 17%
5. Hepacivirus 13%
6. Chronic Hepatitis B 13%
7. Carbapenems 13%
8. Hepatocellular Carcinoma 13%
9. Mortality 12%
10. Hepatitis B virus 11%
11. Pylorus 11%
12. Liver 10%
13. Escherichia coli 10%
14. Aeromonas 9%
15. HIV 9%
16. Genes 9%
17. Systemic Lupus Erythematosus 9%
18. Stomach 9%
19. Serum 8%
20. Hepatitis B e Antigens 8%
21. Neoplasms 8%
22. Chronic Hepatitis C 8%
23. Anti-Bacterial Agents 8%
24. Odds Ratio 8%
25. Virus Diseases 8%
26. Confidence Intervals 8%
27. Incidence 8%
28. Hemorrhage 8%
29. Genotype 7%
30. Helicobacter Infections 7%
31. Renal Dialysis 7%
32. Survival 7%
33. In Vitro Techniques 7%
34. Antiviral Agents 7%
35. Acinetobacter baumannii 6%
36. Chronic Renal Insufficiency 6%
37. entecavir 6%
38. Coronavirus 6%
39. Pneumonia 6%
40. Population 6%
41. Mutation 6%
42. Tigecycline 6%
43. Inflammation 6%
44. Safety 6%
45. Cohort Studies 6%
46. Enterobacteriaceae 6%
47. Hepatitis B 6%
48. Lung 6%
49. Peritoneal Dialysis 5%
50. Lung Neoplasms 5%
51. Myocardial Infarction 5%
52. Multicenter Studies 5%
53. Intensive Care Units 5%
54. Acute Coronary Syndrome 5%
55. Guidelines 5%
56. Non-Small Cell Lung Carcinoma 5%
57. Elderly 5%
58. Kidney 5%
59. Cardiology 5%
60. Hepatitis B Surface Antigens 5%
61. Hypertension 5%
62. Clostridium difficile 5%
63. Fibrosis 5%